Clinical Trials Logo
  1. Home
  2. Atrophic Vaginitis
  3. NCT03294538

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Atrophic Vaginitis Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Cream USP, 0.01% (Teva Pharmaceuticals, USA) to Estrace® Estradiol Vaginal Cream, USP, 0.01% (Warner Chilcott) in the Treatment of Atrophic Vaginitis

Clinical Trial Summary

The objectives of this study were to evaluate the therapeutic equivalence of the Test formulation, generic Estradiol Vaginal Cream United States Pharmacopoeia (USP), 0.01% (Teva Pharmaceuticals, United States of America) to the marketed product, Estrace® Cream estradiol vaginal cream USP, 0.01% (Warner Chilcott) in participants with atrophic vaginitis; to demonstrate the superiority of the Test and Reference (active) treatments over Placebo (vehicle) cream in participants with atrophic vaginitis; and to compare the safety of Test, Reference, and Placebo treatments in participants with atrophic vaginitis.

Clinical Trial Description

Systemic (oral or transdermal patch administration) estrogen therapies have been shown to effectively treat symptoms of atrophic vaginitis but bear undesirable side effects including increased risk of heart attacks, stroke, endometrial cancer, and breast cancer. Topical therapies (creams and transvaginal delivery systems) provide low doses of estrogen to the vaginal mucosa to provide local relief for the symptoms of atrophic vaginitis, while reducing the unwanted side effects associated with systemic delivery systems. Low dose, topical estrogen therapy is considered most appropriate and convenient for the treatment of vaginal symptoms associated with menopause, particularly when other symptoms including bone loss or vasomotor dysfunction do not need to be targeted. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03294538
Study type Interventional
Source Actavis Inc.
Contact
Status Completed
Phase Phase 3
Start date May 18, 2016
Completion date February 15, 2017
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00984399 - Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen N/A
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Recruiting NCT05953090 - VALOR: Vaginal Atrophy & Long-term Observation of Recovery N/A
Terminated NCT00816556 - A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis Phase 3
Completed NCT00167921 - Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis Phase 1
Completed NCT04327947 - Evaluation of Gynecological Acceptability of 3 Health Care Products N/A
Recruiting NCT05118685 - Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis Phase 1
Active, not recruiting NCT05058313 - Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy N/A
Completed NCT02995694 - A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis Phase 3
Completed NCT02691936 - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy N/A
Completed NCT02195986 - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Phase 3
Recruiting NCT03981458 - Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis N/A
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Completed NCT02869165 - Vaginal and Urinary Microbiome Trial Phase 4
Completed NCT02029053 - Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness Phase 0
Not yet recruiting NCT06176820 - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause Phase 2/Phase 3
Recruiting NCT02733731 - The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Phase 1
Withdrawn NCT02460302 - Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy Phase 2
Completed NCT02313545 - Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV Phase 1/Phase 2
Recruiting NCT04219605 - Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions